echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Saisin Pharma completes $100 million round A financing to focus on the development of new drugs for the central nervous system

    Saisin Pharma completes $100 million round A financing to focus on the development of new drugs for the central nervous system

    • Last Update: 2021-01-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On December 8th SciNeuro Pharmaceuticals announced the official launch and completion of a $100m round of A financing, focusing on the development of innovative drugs for patients with central nervous system (CNS) diseases.
    round of financing is jointly led by Lilly Asia Fund and Arch Venture Partners, followed by Boyu Capital, General Atlantic, Sequoia Capital China, Taifu Capital and Zoo Capital.
    will be used to build and develop the CNS portfolio, with the initial focus on Greater China.
    according to the press release, Dr. Limin is a renowned neuroscientist who previously served as a professor at Johns Hopkins University School of Medicine and senior vice president of a major international pharmaceutical company and head of global research and development in neuroscience.
    is also a founding partner of Lilly Asia.
    addition, the core team of Saisan Pharma includes Dr. Qiuqing Ang, Chief Medical Officer, Dr. Danny Chen, Senior Vice President and Director of Translational Sciences, and Dr. Paul Stead, Chief Commercial Officer.
    : sciNeuro Pharmaceuticals Launches to Bring Innovative Treatments for CNS Diseases.Retrieved Dec 8,2020, from | Sessoms Pharma completed a $100 million round of A-round financing.Retrieved Dec 10,2020, from Lilly Asia Capital Source: Pharmaceutical Mission Hills
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.